We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

American Needle: The Supreme Court Evaluates Antitrust Immunity for Joint Ventures‬‪

15 June 2010

Antitrust, Competition and Economic Regulation Alert

Breaking a string of victories for antitrust defendants, a unanimous Supreme Court issued its opinion in American Needle, Inc. v. National Football League on 24 May 2010. The decision treats the conduct of joint ventures comprised of independently owned and independently managed businesses that act as "separate economic actors" and are potential "independent centers of decisionmaking" as the collective action of the venturers and thus subject to challenge under Section 1 of the Sherman Act. Justice Stevens delivered this valedictory antitrust opinion with a warning that even the internal decisions of a lawfully-constituted joint venture among competitors may be treated as concerted action subject to Section 1 of the Sherman Act.

Read "American Needle: The Supreme Court Evaluates Antitrust Immunity for Joint Ventures‬‪"

The team

Loading data